MedPath
FDA Approval

rocuronium bromide

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Hospira, Inc.
DUNS: 141588017
Effective Date
August 29, 2023
Labeling Type
Human Prescription Drug Label
Rocuronium(10 mg in 1 mL)

Manufacturing Establishments2

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Gland Chemicals Private Limited

Hospira, Inc.

862603148

GLAND PHARMA LIMITED

Hospira, Inc.

858971074

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

rocuronium bromide

Product Details

NDC Product Code
0409-1403
Application Number
ANDA205656
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
August 29, 2023
SODIUM ACETATEInactive
Code: 4550K0SC9BClass: IACTQuantity: 2 mg in 1 mL
Code: I65MW4OFHZClass: ACTIBQuantity: 10 mg in 1 mL
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACTQuantity: 3.10 mg in 1 mL
ACETIC ACIDInactive
Code: Q40Q9N063PClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT

rocuronium bromide

Product Details

NDC Product Code
0409-5160
Application Number
ANDA205656
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
August 29, 2023
Code: I65MW4OFHZClass: ACTIBQuantity: 10 mg in 1 mL
ACETIC ACIDInactive
Code: Q40Q9N063PClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
SODIUM ACETATEInactive
Code: 4550K0SC9BClass: IACTQuantity: 2 mg in 1 mL
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACTQuantity: 3.10 mg in 1 mL
© Copyright 2025. All Rights Reserved by MedPath